• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Kiniksa Pharmaceuticals International Plc (NQ: KNSA )

    26.74 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 26.74
    Bid (Size) 24.33 (2)
    Ask (Size) 27.98 (15)
    Prev. Close 26.74
    Today's Range 26.74 - 26.74
    52wk Range 14.12 - 27.92
    Shares Outstanding 71,004,640
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    KNSA Stock Earnings: Kiniksa Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
    KNSA stock results show that Kiniksa Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    +44.31%
    +44.31%
    1 Month
    +10.91%
    +10.91%
    3 Month
    +35.67%
    +35.67%
    6 Month
    +32.44%
    +32.44%
    1 Year
    +58.22%
    +58.22%

    More News

    Read More
    Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Earnings Outlook For Kiniksa Pharmaceuticals
    Via Benzinga
    Sector Spotlight: Orphan Drug Developers With Significant Upside
    Via AB Newswire
    Topics ETFs
    Exposures Product Safety
    Sector Spotlight: Orphan Drug Developers With Significant Upside
    Via TheNewswire.com
    Topics ETFs
    Exposures Product Safety
    KNSA Stock Earnings: Kiniksa Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    The 3 Most Undervalued Biotech Stocks to Buy in December
    Via InvestorPlace
    7 Underappreciated Biotech Stocks to Pick Up on the Cheap
    Via InvestorPlace
    Topics Economy
    Exposures Economy
    Earnings Outlook For Kiniksa Pharmaceuticals
    Via Benzinga
    Why Shares of Kiniksa Pharmaceuticals Jumped Tuesday
    Via The Motley Fool
    Kiniksa Pharmaceuticals Ltd. (NASDAQ: KNSA) Near the Top of Equities by Percentage Gain on 7/25
    Via Investor Brand Network
    Earnings Scheduled For April 23, 2024
    Via Benzinga
    Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Amicus Therapeutics Stock Reaches 80+ Relative Strength Benchmark
    Via Investor's Business Daily
    5 Value Stocks In The Healthcare Sector
    Via Benzinga
    5 Value Stocks To Watch In The Healthcare Sector
    Via Benzinga
    Vertex Pharmaceuticals Stock Shows Rising Relative Strength, Hits 80+
    Via Investor's Business Daily
    ACELYRIN Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold
    Via Investor's Business Daily
    Axsome Therapeutics Stock Earns Relative Strength Rating Upgrade
    Via Investor's Business Daily
    Exelixis Stock Sees Rising Relative Strength Rating
    Via Investor's Business Daily
    Dynavax Technologies Stock Sees Renewed Technical Strength
    Via Investor's Business Daily
    Crude Oil Up 1%; Verizon Earnings Beat Views
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.